{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:13:09Z","timestamp":1772172789570,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11307-023-01855-0","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T14:02:20Z","timestamp":1695045740000},"page":"435-447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating Tumor Hypoxia Radiosensitization Via Electron Paramagnetic Resonance Oxygen Imaging (EPROI)"],"prefix":"10.1007","volume":"26","author":[{"given":"Ashlyn G.","family":"Rickard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9839-2414","authenticated-orcid":false,"given":"Yvonne M.","family":"Mowery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Bassil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas C.","family":"Rouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerissa T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Charity","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafaela","family":"Belloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Crouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nimmi","family":"Ramanujam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rico","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Blocker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Epel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrignayani","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"issue":"2","key":"1855_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","volume":"26","author":"P Vaupel","year":"2007","unstructured":"Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26(2):225\u2013239","journal-title":"Cancer Metastasis Rev"},{"issue":"8","key":"1855_CR2","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1089\/ars.2007.1623","volume":"9","author":"EJ Moon","year":"2007","unstructured":"Moon EJ, Brizel DM, Chi JT, Dewhirst MW (2007) The potential role of intrinsic hypoxia markers as prognostic variables in cancer. Antioxid Redox Signal 9(8):1237\u20131294","journal-title":"Antioxid Redox Signal"},{"key":"1855_CR3","first-page":"519","volume":"2","author":"I Churchill-Davidson","year":"1964","unstructured":"Churchill-Davidson I (1964) High-pressure oxygen and radiotherapy. Anglo Ger Med Rev 2:519\u2013523","journal-title":"Anglo Ger Med Rev"},{"key":"1855_CR4","first-page":"S271","volume":"27","author":"M Saunders","year":"1996","unstructured":"Saunders M, Dische S (1996) Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide. Br J Cancer Suppl 27:S271\u2013S278","journal-title":"Br J Cancer Suppl"},{"issue":"1093","key":"1855_CR5","doi-asserted-by":"publisher","first-page":"20170915","DOI":"10.1259\/bjr.20170915","volume":"92","author":"P Wardman","year":"2019","unstructured":"Wardman P (2019) Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes. Br J Radiol 92(1093):20170915","journal-title":"Br J Radiol"},{"issue":"1","key":"1855_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/157488406775268192","volume":"1","author":"L Marcu","year":"2006","unstructured":"Marcu L, Olver I (2006) Tirapazamine: from bench to clinical trials. Curr Clin Pharmacol 1(1):71\u201379","journal-title":"Curr Clin Pharmacol"},{"issue":"4","key":"1855_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2174\/156652409788167087","volume":"9","author":"S Rockwell","year":"2009","unstructured":"Rockwell S, Dobrucki IT, Kim EY, Marrison ST, Vu VT (2009) Hypoxia and radiation therapy: past history, ongoing research, and future promise. Curr Mol Med 9(4):442\u2013458","journal-title":"Curr Mol Med"},{"issue":"2","key":"1855_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1053\/j.semnuclmed.2014.10.004","volume":"45","author":"CJ Koch","year":"2015","unstructured":"Koch CJ, Evans SM (2015) Optimizing hypoxia detection and treatment strategies. Semin Nucl Med 45(2):163\u2013176","journal-title":"Semin Nucl Med"},{"key":"1855_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-3-030-12734-3_2","volume":"1136","author":"AG Rickard","year":"2019","unstructured":"Rickard AG, Palmer GM, Dewhirst MW (2019) Clinical and pre-clinical methods for quantifying tumor hypoxia. Adv Exp Med Biol 1136:19\u201341","journal-title":"Adv Exp Med Biol"},{"key":"1855_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.freeradbiomed.2018.08.019","volume":"126","author":"P Bonnitcha","year":"2018","unstructured":"Bonnitcha P, Grieve S, Figtree G (2018) Clinical imaging of hypoxia: current status and future directions. Free Radic Biol Med 126:296\u2013312","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1855_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S1053-4296(96)80032-4","volume":"6","author":"J Overgaard","year":"1996","unstructured":"Overgaard J, Horsman MR (1996) Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol 6(1):10\u201321","journal-title":"Semin Radiat Oncol"},{"issue":"2","key":"1855_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/mrm.24926","volume":"72","author":"B Epel","year":"2014","unstructured":"Epel B, Bowman MK, Mailer C, Halpern HJ (2014) Absolute oxygen r1e imaging in vivo with pulse electron paramagnetic resonance. Magn Reson Med 72(2):362\u2013368","journal-title":"Magn Reson Med"},{"key":"1855_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-4939-0620-8_15","volume":"812","author":"B Epel","year":"2014","unstructured":"Epel B, Redler G, Halpern HJ (2014) How in vivo epr measures and images oxygen. Adv Exp Med Biol 812:113\u2013119","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"1855_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1089\/ten.tec.2022.0061","volume":"28","author":"N Viswakarma","year":"2022","unstructured":"Viswakarma N, Siddiqui E, Patel S, Hameed S, Schreiber W, Swartz HM, Epel B, Kotecha M (2022) In vivo partial oxygen pressure assessment in subcutaneous and intraperitoneal sites using imaging of solid oxygen probe. Tissue Eng Part C Methods 28(6):264\u2013271","journal-title":"Tissue Eng Part C Methods"},{"issue":"1","key":"1855_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/ten.tec.2017.0236","volume":"24","author":"M Kotecha","year":"2018","unstructured":"Kotecha M, Epel B, Ravindran S, Dorcemus D, Nukavarapu S, Halpern H (2018) Noninvasive absolute electron paramagnetic resonance oxygen imaging for the assessment of tissue graft oxygenation. Tissue Eng Part C Methods 24(1):14\u201319","journal-title":"Tissue Eng Part C Methods"},{"issue":"6","key":"1855_CR16","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1118\/1.3425787","volume":"37","author":"B Epel","year":"2010","unstructured":"Epel B, Haney CR, Hleihel D, Wardrip C, Barth ED, Halpern HJ (2010) Electron paramagnetic resonance oxygen imaging of a rabbit tumor using localized spin probe delivery. Med Phys 37(6):2553\u20132559","journal-title":"Med Phys"},{"issue":"5","key":"1855_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/nbm.900","volume":"17","author":"B Gallez","year":"2004","unstructured":"Gallez B, Baudelet C, Jordan BF (2004) Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications. NMR Biomed 17(5):240\u2013262","journal-title":"NMR Biomed"},{"issue":"5","key":"1855_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/nbm.897","volume":"17","author":"S Subramanian","year":"2004","unstructured":"Subramanian S, Matsumoto K, Mitchell JB, Krishna MC (2004) Radio frequency continuous-wave and time-domain epr imaging and overhauser-enhanced magnetic resonance imaging of small animals: instrumental developments and comparison of relative merits for functional imaging. NMR Biomed 17(5):263\u2013294","journal-title":"NMR Biomed"},{"issue":"1-2","key":"1855_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1023\/A:1015967305659","volume":"234-235","author":"G Ilangovan","year":"2002","unstructured":"Ilangovan G, Li H, Zweier JL, Kuppusamy P (2002) In vivo measurement of tumor redox environment using epr spectroscopy. Mol Cell Biochem 234-235(1-2):393\u2013398","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"1855_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ijrobp.2008.02.022","volume":"71","author":"M Elas","year":"2008","unstructured":"Elas M, Bell R, Hleihel D, Barth ED, McFaul C, Haney CR, Bielanska J, Pustelny K, Ahn KH, Pelizzari CA et al (2008) Electron paramagnetic resonance oxygen image hypoxic fraction plus radiation dose strongly correlates with tumor cure in fsa fibrosarcomas. Int J Radiat Oncol Biol Phys 71(2):542\u2013549","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1855_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-1-4939-0620-8_16","volume":"812","author":"G Redler","year":"2014","unstructured":"Redler G, Epel B, Halpern HJ (2014) What we learn from in vivo epr oxygen images. Adv Exp Med Biol 812:121\u2013126","journal-title":"Adv Exp Med Biol"},{"key":"1855_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-3-319-55231-6_39","volume":"977","author":"B Epel","year":"2017","unstructured":"Epel B, Maggio M, Pelizzari C, Halpern HJ (2017) Electron paramagnetic resonance po2 image tumor oxygen-guided radiation therapy optimization. Adv Exp Med Biol 977:287\u2013296","journal-title":"Adv Exp Med Biol"},{"issue":"3-4","key":"1855_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12013-017-0825-2","volume":"75","author":"B Epel","year":"2017","unstructured":"Epel B, Krzykawska-Serda M, Tormyshev V, Maggio MC, Barth ED, Pelizzari CA, Halpern HJ (2017) Spin lattice relaxation epr po2 images may direct the location of radiation tumor boosts to enhance tumor cure. Cell Biochem Biophys 75(3-4):295\u2013298","journal-title":"Cell Biochem Biophys"},{"key":"1855_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jmr.2017.04.017","volume":"280","author":"B Epel","year":"2017","unstructured":"Epel B, Kotecha M, Halpern HJ (2017) In vivo preclinical cancer and tissue engineering applications of absolute oxygen imaging using pulse epr. J Magn Reson 280:149\u2013157","journal-title":"J Magn Reson"},{"issue":"42","key":"1855_CR25","doi-asserted-by":"publisher","first-page":"10756","DOI":"10.1073\/pnas.1808945115","volume":"115","author":"M Benej","year":"2018","unstructured":"Benej M, Hong X, Vibhute S, Scott S, Wu J, Graves E, Le QT, Koong AC, Giaccia AJ, Yu B et al (2018) Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism. Proc Natl Acad Sci U S A 115(42):10756\u201310761","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1855_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1117\/1.JBO.23.5.057004","volume":"23","author":"GM Palmer","year":"2018","unstructured":"Palmer GM, Zhang H, Lee CT, Mikati H, Herbert JA, Krieger M, von Windheim J, Koester D, Stevenson D, Rocke DJ et al (2018) Assessing effects of pressure on tumor and normal tissue physiology using an automated self-calibrated, pressure-sensing probe for diffuse reflectance spectroscopy. J Biomed Opt 23(5):1\u20138","journal-title":"J Biomed Opt"},{"key":"1855_CR27","doi-asserted-by":"crossref","unstructured":"Lee CL, Mowery YM, Daniel AR, Zhang D, Sibley AB, Delaney JR, Wisdom AJ, Qin X, Wang X, Caraballo I et al (2019) Mutational landscape in genetically engineered, carcinogen-induced, and radiation-induced mouse sarcoma. JCI Insight 4(13)","DOI":"10.1172\/jci.insight.128698"},{"issue":"1","key":"1855_CR28","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1038\/s41467-021-26126-w","volume":"12","author":"LH Wang","year":"2021","unstructured":"Wang LH, Ernst AU, An D, Datta AK, Epel B, Kotecha M, Ma M (2021) A bioinspired scaffold for rapid oxygenation of cell encapsulation systems. Nat Commun 12(1):5846","journal-title":"Nat Commun"},{"key":"1855_CR29","doi-asserted-by":"crossref","unstructured":"Lu W, Miao R, Hu S, Liu J, Jin F, Zhang RX (2021) Microsurgical skills of establishing permanent jugular vein cannulation in rats for serial blood sampling of orally administered drug. J Vis Exp 178","DOI":"10.3791\/63167"},{"issue":"1","key":"1855_CR30","doi-asserted-by":"publisher","first-page":"6410","DOI":"10.1038\/s41467-020-19917-0","volume":"11","author":"AJ Wisdom","year":"2020","unstructured":"Wisdom AJ, Mowery YM, Hong CS, Himes JE, Nabet BY, Qin X, Zhang D, Chen L, Fradin H, Patel R et al (2020) Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy. Nat Commun 11(1):6410","journal-title":"Nat Commun"},{"issue":"5","key":"1855_CR31","first-page":"193","volume":"16","author":"ER Garrett","year":"1978","unstructured":"Garrett ER, Roseboom H, Green JR Jr, Schuermann W (1978) Pharmacokinetics of papaverine hydrochloride and the biopharmaceutics of its oral dosage forms. Int J Clin Pharmacol Biopharm 16(5):193\u2013208","journal-title":"Int J Clin Pharmacol Biopharm"},{"issue":"5","key":"1855_CR32","first-page":"227","volume":"15","author":"WA Ritschel","year":"1977","unstructured":"Ritschel WA, Hammer GV (1977) Pharmacokinetics of papaverine in man. Int J Clin Pharmacol Biopharm 15(5):227\u2013228","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"1855_CR33","doi-asserted-by":"crossref","unstructured":"Guerin MV, Finisguerra V, Van den Eynde BJ, Bercovici N, Trautmann A (2020) Preclinical murine tumor models: a structural and functional perspective. Elife 9","DOI":"10.7554\/eLife.50740"},{"key":"1855_CR34","first-page":"339","volume":"22","author":"J Folkman","year":"1991","unstructured":"Folkman J, Hanahan D (1991) Switch to the angiogenic phenotype during tumorigenesis. Princess Takamatsu Symp 22:339\u2013347","journal-title":"Princess Takamatsu Symp"},{"issue":"3","key":"1855_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86(3):353\u2013364","journal-title":"Cell."},{"issue":"4","key":"1855_CR36","first-page":"550","volume":"66","author":"S Wood Jr","year":"1958","unstructured":"Wood S Jr (1958) Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber. AMA Arch Pathol 66(4):550\u2013568","journal-title":"AMA Arch Pathol"},{"issue":"6","key":"1855_CR37","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1667\/RR1926.1","volume":"172","author":"MW Dewhirst","year":"2009","unstructured":"Dewhirst MW (2009) Relationships between cycling hypoxia, hif-1, angiogenesis and oxidative stress. Radiat Res 172(6):653\u2013665","journal-title":"Radiat Res"},{"key":"1855_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fonc.2015.00165","volume":"5","author":"G Baronzio","year":"2015","unstructured":"Baronzio G, Parmar G, Baronzio M (2015) Overview of methods for overcoming hindrance to drug delivery to tumors, with special attention to tumor interstitial fluid. Front Oncol 5:165","journal-title":"Front Oncol"},{"issue":"4","key":"1855_CR39","first-page":"335","volume":"28","author":"S Dou","year":"2013","unstructured":"Dou S, Smith M, Wang Y, Rusckowski M, Liu G (2013) Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapy. Cancer Biother Radiopharm 28(4):335\u2013342","journal-title":"Cancer Biother Radiopharm"},{"key":"1855_CR40","doi-asserted-by":"crossref","unstructured":"Subhan MA, Yalamarty SSK, Filipczak N, Parveen F, Torchilin VP (2021) Recent advances in tumor targeting via EPR effect for cancer treatment. J Pers Med 11(6)","DOI":"10.3390\/jpm11060571"},{"issue":"3","key":"1855_CR41","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1039\/C8CS00304A","volume":"48","author":"A Sharma","year":"2019","unstructured":"Sharma A, Arambula JF, Koo S, Kumar R, Singh H, Sessler JL, Kim JS (2019) Hypoxia-targeted drug delivery. Chem Soc Rev 48(3):771\u2013813","journal-title":"Chem Soc Rev"},{"issue":"4","key":"1855_CR42","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1158\/0008-5472.CAN-15-2818","volume":"76","author":"MW Dewhirst","year":"2016","unstructured":"Dewhirst MW, Birer SR (2016) Oxygen-enhanced mri is a major advance in tumor hypoxia imaging. Cancer Res 76(4):769\u2013772","journal-title":"Cancer Res"},{"key":"1855_CR43","doi-asserted-by":"crossref","unstructured":"G\u00e9rard M, Corroyer-Dulmont A, Lesueur P, Collet S, Ch\u00e9rel M, Bourgeois M, Stefan D, Limkin EJ, Perrio C, Guillamo JS et al (2019) Hypoxia imaging and adaptive radiotherapy: a state-of-the-art approach in the management of glioma. Front Med-Lausanne 6","DOI":"10.3389\/fmed.2019.00117"},{"key":"1855_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-1-4939-3023-4_23","volume":"876","author":"B Epel","year":"2016","unstructured":"Epel B, Redler G, Pelizzari C, Tormyshev VM, Halpern HJ (2016) Approaching oxygen-guided intensity-modulated radiation therapy. Oxygen Transport to Tissue Xxxvii 876:185\u2013193","journal-title":"Oxygen Transport to Tissue Xxxvii"},{"key":"1855_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-3-319-55231-6_39","volume":"977","author":"B Epel","year":"2017","unstructured":"Epel B, Maggio M, Pelizzari C, Halpern HJ (2017) Electron paramagnetic resonance po(2) image tumor oxygen-guided radiation therapy optimization. Oxygen Transport to Tissue Xxxix 977:287\u2013296","journal-title":"Oxygen Transport to Tissue Xxxix"},{"issue":"4","key":"1855_CR46","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.ijrobp.2018.10.041","volume":"103","author":"B Epel","year":"2019","unstructured":"Epel B, Maggio MC, Barth ED, Miller RC, Pelizzari CA, Krzykawska-Serda M, Sundramoorthy SV, Aydogan B, Weichselbaum RR, Tormyshev VM et al (2019) Oxygen-guided radiation therapy. Int J Radiat Oncol 103(4):977\u2013984","journal-title":"Int J Radiat Oncol"},{"issue":"3","key":"1855_CR47","first-page":"e21","volume":"52","author":"C Constantinides","year":"2011","unstructured":"Constantinides C, Mean R, Janssen BJ (2011) Effects of isoflurane anesthesia on the cardiovascular function of the c57bl\/6 mouse. ILAR J 52(3):e21\u2013e31","journal-title":"ILAR J"},{"issue":"7","key":"1855_CR48","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1364\/BOE.456125","volume":"13","author":"AG Rickard","year":"2022","unstructured":"Rickard AG, Zhuang M, DeRosa CA, Dewhirst MW, Fraser CL, Palmer GM (2022) Quantifying the effects of anesthesia on intracellular oxygen via low-cost portable microscopy using dual-emissive nanoparticles. Biomed Opt Express 13(7):3869\u20133881","journal-title":"Biomed Opt Express"},{"key":"1855_CR49","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.2147\/IJN.S324314","volume":"16","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wang H, Suo W, Li Z, Yang C (2021) Penetration enhancing of an erythrocyte-mimicking nanoplatform via papaverine for radiosensitization. Int J Nanomedicine 16:6923\u20136935","journal-title":"Int J Nanomedicine"},{"key":"1855_CR50","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fphar.2012.00094","volume":"3","author":"BF Jordan","year":"2012","unstructured":"Jordan BF, Sonveaux P (2012) Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy. Front Pharmacol 3:94","journal-title":"Front Pharmacol"},{"issue":"18","key":"1855_CR51","first-page":"4264","volume":"56","author":"Y Boucher","year":"1996","unstructured":"Boucher Y, Leunig M, Jain RK (1996) Tumor angiogenesis and interstitial hypertension. Cancer Res 56(18):4264\u20134266","journal-title":"Cancer Res"},{"issue":"18","key":"1855_CR52","first-page":"5381","volume":"62","author":"DM McDonald","year":"2002","unstructured":"McDonald DM, Baluk P (2002) Significance of blood vessel leakiness in cancer. Cancer Res 62(18):5381\u20135385","journal-title":"Cancer Res"},{"issue":"9","key":"1855_CR53","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S1359-6446(03)02686-2","volume":"8","author":"LL Munn","year":"2003","unstructured":"Munn LL (2003) Aberrant vascular architecture in tumors and its importance in drug-based therapies. Drug Discov Today 8(9):396\u2013403","journal-title":"Drug Discov Today"},{"key":"1855_CR54","doi-asserted-by":"crossref","unstructured":"Naghavi\u00a0AO, Yang GQ, Latifi K, Gillies R, McLeod H, Harrison LB (2018) The future of radiation oncology in soft tissue sarcoma. Cancer Control 25","DOI":"10.1177\/1073274818815504"},{"issue":"1","key":"1855_CR55","first-page":"1","volume":"9","author":"E Ortiz-Prado","year":"2019","unstructured":"Ortiz-Prado E, Dunn JF, Vasconez J, Castillo D, Viscor G (2019) Partial pressure of oxygen in the human body: a general review. Am J Blood Res 9(1):1\u201314","journal-title":"Am J Blood Res"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-023-01855-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-023-01855-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-023-01855-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T19:34:03Z","timestamp":1719516843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-023-01855-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1855"],"URL":"https:\/\/doi.org\/10.1007\/s11307-023-01855-0","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,18]]},"assertion":[{"value":"3 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GMP, BC, NR, DS, and Duke University have financial interest in Zenalux Biomedical, Inc. which is commercializing the Zenascope. BE and MK have financial interest in O2M Technologies, LLC. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}